These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 36975415)

  • 1.
    Li D; Huang S; Luo C; Xu Y; Fu S; Liu K; Wu J
    Curr Oncol; 2023 Feb; 30(3):2653-2672. PubMed ID: 36975415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in the Study of Chemokine-like Factor Superfamily Members in Tumors].
    Xie G; Cheng J; Zhang J
    Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):46-51. PubMed ID: 36792080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma.
    Tan S; Guo X; Bei C; Zhang H; Li D; Zhu X; Tan H
    BMC Cancer; 2022 Aug; 22(1):905. PubMed ID: 35986302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer.
    Wu K; Li X; Gu H; Yang Q; Liu Y; Wang L
    Int J Biol Sci; 2019; 15(12):2576-2583. PubMed ID: 31754330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells.
    Li W; Zhang S
    Oncol Res; 2017 Jan; 25(2):285-293. PubMed ID: 27629543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors.
    Duan SL; Jiang Y; Li GQ; Fu W; Song Z; Li LN; Li J
    PeerJ; 2024; 12():e16757. PubMed ID: 38223763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analysis of CMTM family in pan-cancer and preliminary exploration of CMTM6 in bladder cancer.
    Xu Y; Li Q; Lin H
    Cell Signal; 2024 Mar; 115():111012. PubMed ID: 38113979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.
    Chui NN; Cheu JW; Yuen VW; Chiu DK; Goh CC; Lee D; Zhang MS; Ng IO; Wong CC
    Hepatol Commun; 2022 Jan; 6(1):178-193. PubMed ID: 34558800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated CMTM2 Poses Potential Clinical Significance in Hepatocellular Carcinoma.
    Guo X; Zhang S; Tan S; Bei C; Zhang H; Zhu X; Qiu X
    DNA Cell Biol; 2020 Apr; 39(4):683-689. PubMed ID: 31990600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine-like factor-like MARVEL transmembrane domain-containing family in autoimmune diseases.
    Duan HJ; Li XY; Liu C; Deng XL
    Chin Med J (Engl); 2020 Apr; 133(8):951-958. PubMed ID: 32195671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMTM5/7 are biomarkers and prognostic factors in human breast carcinoma.
    Wu J
    Cancer Biomark; 2020; 29(1):89-99. PubMed ID: 32568178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of CMTM4 expression in hepatocellular carcinoma.
    Bei C; Zhang Y; Wei R; Zhu X; Wang Z; Zeng W; Chen Q; Tan S
    Onco Targets Ther; 2017; 10():5439-5443. PubMed ID: 29180877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of the prognostic value of the chemokine-like factor-like MARVEL transmembrane domain-containing family in gastric cancer.
    Liang Z; Xie J; Huang L; Huang Y; Zhang Y; Ma R; Zheng Z; Wang Q; Li X
    J Gastrointest Oncol; 2021 Apr; 12(2):388-406. PubMed ID: 34012634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CMTM7 inhibits cell growth and migration in liver cancer.
    Huang ZM; Li PL; Yang P; Hou XD; Yang YL; Xu X; Xu F
    Kaohsiung J Med Sci; 2019 Jun; 35(6):332-340. PubMed ID: 30903681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible effects of chemokine-like factor-like MARVEL transmembrane domain-containing family on antiphospholipid syndrome.
    Ge YY; Duan HJ; Deng XL
    Chin Med J (Engl); 2021 Apr; 134(14):1661-1668. PubMed ID: 33813507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
    Yu ZL; Zhu ZM
    Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Polymorphisms in CMTM Family Genes and Hepatocellular Carcinoma in Guangxi of China.
    Bei C; Tan C; Zhu X; Wang Z; Tan S
    DNA Cell Biol; 2018 Aug; 37(8):691-696. PubMed ID: 29990439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets.
    Delic S; Thuy A; Schulze M; Proescholdt MA; Dietrich P; Bosserhoff AK; Riemenschneider MJ
    Genes Chromosomes Cancer; 2015 Jul; 54(7):433-43. PubMed ID: 25931111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine-Like Factor-Like MARVEL Transmembrane Domain-Containing Family in Hepatocellular Carcinoma: Latest Advances.
    Li M; Luo F; Tian X; Yin S; Zhou L; Zheng S
    Front Oncol; 2020; 10():595973. PubMed ID: 33282744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic biomarkers in the CMTM family genes of human ovarian cancer through bioinformatics analysis and experimental verification.
    Zhang M; Wang J; Yue H; Zhang L
    Front Genet; 2022; 13():918319. PubMed ID: 36110202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.